{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:42:17Z","timestamp":1792636937440,"version":"4.5.0"},"reference-count":328,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM123508"],"award-info":[{"award-number":["R01GM123508"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Acute inflammation or resolved inflammation is an adaptive host defense mechanism and is self-limiting, which returns the body to a state of homeostasis. However, unresolved, uncontrolled, or chronic inflammation may lead to various maladies, including cancer. Important evidence that links inflammation and cancer is that nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, reduce the risk and mortality from many cancers. The fact that NSAIDs inhibit the eicosanoid pathway prompted mechanistic drug developmental work focusing on cyclooxygenase (COX) and its products. The increased prostaglandin E2 levels and the overexpression of COX-2 in the colon and many other cancers provided the rationale for clinical trials with COX-2 inhibitors for cancer prevention or treatment. However, NSAIDs do not require the presence of COX-2 to prevent cancer. In this review, we highlight the effects of NSAIDs and selective COX-2 inhibitors (COXIBs) on targets beyond COX-2 that have shown to be important against many cancers. Finally, we hone in on specialized pro-resolving mediators (SPMs) that are biosynthesized locally and, in a time, -dependent manner to promote the resolution of inflammation and subsequent tissue healing. Different classes of SPMs are reviewed, highlighting aspirin\u2019s potential in triggering the production of these resolution-promoting mediators (resolvins, lipoxins, protectins, and maresins), which show promise in inhibiting cancer growth and metastasis.<\/jats:p>","DOI":"10.3390\/ijms23031432","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T22:00:56Z","timestamp":1643320856000},"page":"1432","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase"],"prefix":"10.3390","volume":"23","author":[{"given":"Oluwafunke R.","family":"Kolawole","sequence":"first","affiliation":[{"name":"Department of Molecular, Cellular and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medicine, New York, NY 10031, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4060-7283","authenticated-orcid":false,"given":"Khosrow","family":"Kashfi","sequence":"additional","affiliation":[{"name":"Department of Molecular, Cellular and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medicine, New York, NY 10031, USA"},{"name":"Graduate Program in Biology, City University of New York Graduate Center, New York, NY 10091, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ley, K. (2001). Physiology of Inflammation, Springer.","DOI":"10.1007\/978-1-4614-7512-5"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1054-3589(08)57002-5","article-title":"Anti-inflammatory agents as cancer therapeutics","volume":"57","author":"Kashfi","year":"2009","journal-title":"Adv. Pharm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Mantovani Inflammation and cancer: Back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jtbi.2004.04.044","article-title":"The dynamics of acute inflammation","volume":"230","author":"Kumar","year":"2004","journal-title":"J. Theor. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/prd.12034","article-title":"Natural resolution of inflammation","volume":"63","author":"Freire","year":"2013","journal-title":"Periodontol. 2000"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving Inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic pharmacologic and clinical issues","volume":"94","author":"Thun","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer","volume":"348","author":"Sandler","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/annonc\/mdu578","article-title":"Low-dose aspirin use and the risk of ovarian cancer in Denmark","volume":"26","author":"Baandrup","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin nonaspirin nonsteroidal anti-inflammatory drug and acetaminophen use and risk of invasive epithelial ovarian cancer: A pooled analysis in the Ovarian Cancer Association Consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/bjc.2012.227","article-title":"Aspirin but not ibuprofen use is associated with reduced risk of Prostate cancer: A PLCO study","volume":"107","author":"Shebl","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/jnci\/djs452","article-title":"Nonsteroidal anti-inflammatory drug use chronic liver disease and hepatocellular carcinoma","volume":"104","author":"Sahasrabuddhe","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_15","first-page":"276","article-title":"Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial","volume":"18","author":"Clouser","year":"2009","journal-title":"Pharm. Drug Saf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/jnci\/djq442","article-title":"Chemoprevention of nonmelanoma skin cancer with celecoxib: A randomized double-blind placebo-controlled trial","volume":"102","author":"Elmets","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1442-2050.2011.01198.x","article-title":"Meta-analysis: Non-steroidal anti-inflammatory drug use and the risk of esophageal squamous Cell carcinoma","volume":"24","author":"Sun","year":"2011","journal-title":"Dis. Esophagus"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MPA.0b013e3182a8d41f","article-title":"High-dose aspirin consumption contributes to decreased risk for pancreatic cancer in a systematic review and meta-analysis","volume":"43","author":"Cui","year":"2014","journal-title":"Pancreas"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/CEJ.0000000000000098","article-title":"Aspirin and NSAIDs for breast cancer chemoprevention","volume":"24","author":"Yiannakopoulou","year":"2015","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10549-015-3267-9","article-title":"Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: A meta-analysis","volume":"149","author":"Baeza","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/aje\/kwq437","article-title":"Nonsteroidal antiinflammatory drugs and bladder cancer: A pooled analysis","volume":"173","author":"Daugherty","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/1940-6207.CAPR-13-0164","article-title":"Preventive effects of NSAIDs NO-NSAIDs and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model","volume":"7","author":"Nicastro","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/ijc.29601","article-title":"Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis","volume":"137","author":"Becker","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence mortality and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharm. Rev."},{"key":"ref_27","unstructured":"Brunton, L., Knollman, B., and Hilal-Dandan, R. (2017). Goodman and Gilman\u2019s the Pharmacological Basis of Therapeutics, McGraw-Hill Education\/Medical."},{"key":"ref_28","first-page":"34","article-title":"NSAIDs: Uses effects risks and benefits","volume":"43","author":"Booker","year":"2013","journal-title":"Pract. Nurse"},{"key":"ref_29","first-page":"715","article-title":"A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation","volume":"37","author":"Gryglewski","year":"1978","journal-title":"Acta Biol. Med. Ger."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1590-8658(01)80152-3","article-title":"Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents","volume":"33","author":"Fiorucci","year":"2001","journal-title":"Dig. Liver Dis."},{"key":"ref_31","first-page":"4399","article-title":"Colorectal cancer risk chronic illnesses operations and medications: Case-control results from the Melbourne Colorectal Cancer Study","volume":"48","author":"Kune","year":"1988","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.breast.2010.07.004","article-title":"Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk","volume":"20","author":"Ashok","year":"2011","journal-title":"Breast"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ijc.1376","article-title":"Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor Cell migration invasiveness and angiogenesis","volume":"93","author":"Rozic","year":"2001","journal-title":"Int. J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"242ra84","DOI":"10.1126\/scitranslmed.3008455","article-title":"COX-2 Inhibition Potentiates Antiangiogenic Cancer Therapy and Prevents Metastasis in Preclinical Models","volume":"6","author":"Xu","year":"2014","journal-title":"Sci. Trans. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jamaoncol.2018.4149","article-title":"Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses\u2019 Health Studies","volume":"4","author":"Barnard","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9343(99)00362-9","article-title":"Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: Risk factors and frequency of complications","volume":"107","author":"Bjorkman","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1152\/physrev.00004.2008","article-title":"Prostaglandins NSAIDs and gastric mucosal protection: Why doesn\u2019t the stomach digest itself?","volume":"88","author":"Wallace","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.bcp.2005.05.004","article-title":"Non-COX-2 targets and cancer: Expanding the molecular target repertoire of chemoprevention","volume":"70","author":"Kashfi","year":"2005","journal-title":"Biochem. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/gut.28.3.315","article-title":"Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues","volume":"28","author":"Bennett","year":"1987","journal-title":"Gut"},{"key":"ref_40","first-page":"518","article-title":"Altered eicosanoid levels in human colon cancer","volume":"122","author":"Rigas","year":"1993","journal-title":"J. Lab. Clin. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and carcinomas","volume":"107","author":"Eberhart","year":"1994","journal-title":"Gastroenterology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.3748\/wjg.v21.i20.6206","article-title":"Expression of COX-2 and HER-2 in colorectal cancer and their correlation","volume":"21","author":"Wu","year":"2015","journal-title":"World J. Gastroenterol. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.7150\/ijms.44439","article-title":"The Role of Cyclooxygenase-2 in Colorectal Cancer","volume":"17","author":"Sheng","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1535-6108(03)00310-6","article-title":"Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise","volume":"4","author":"Dannenberg","year":"2003","journal-title":"Cancer Cancer Cell Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81988-1","article-title":"Suppression of intestinal polyposis in Apc\u00d0716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)","volume":"87","author":"Oshima","year":"1996","journal-title":"Cell"},{"key":"ref_46","first-page":"1638","article-title":"Celecoxib as adjunctive therapy for treatment of colorectal cancer","volume":"35","author":"North","year":"2001","journal-title":"Ann. Pharm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-2952(96)00181-5","article-title":"Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer Cells by a prostaglandin-independent pathway","volume":"52","author":"Hanif","year":"1996","journal-title":"Biochem. Pharm."},{"key":"ref_48","first-page":"1679","article-title":"Induction of apoptotic cell death in human colorectal carcinoma Cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug\u2014Independence from COX-2 protein expression","volume":"3","author":"Elder","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-03-0463","article-title":"Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments","volume":"10","author":"Dang","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/ijc.11164","article-title":"Increased toxicity and lack of efficacy of Rofecoxib in combination with chemotherapy for treatment of metastatic colorectal cancer: A phase II study","volume":"105","author":"Becerra","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3389\/fimmu.2018.01859","article-title":"Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation","volume":"9","author":"Park","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/187152312803476255","article-title":"Clinical pharmacology of non-steroidal anti-inflammatory drugs: A review. Antiinflamm","volume":"11","author":"Bacchi","year":"2012","journal-title":"Antiallergy Agents Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.gtc.2009.03.001","article-title":"Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: Looking to the future","volume":"38","author":"Fiorucci","year":"2009","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tips.2009.01.001","article-title":"Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis","volume":"30","author":"Wallace","year":"2009","journal-title":"Trends Pharm. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"f3533","DOI":"10.1136\/bmj.f3533","article-title":"High dose NSAIDs may double the risk of heart attacks and heart failure says new study","volume":"346","author":"Chinthapalli","year":"2013","journal-title":"BMJ"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.2174\/092986711796642508","article-title":"COXIBs CINODs and HS-releasing NSAIDs: Current perspectives in the development of safer non steroidal anti-inflammatory drugs","volume":"18","author":"Fiorucci","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/clc.22814","article-title":"Cardiovascular safety of NSAIDs: Additional insights after PRECISION and point of view","volume":"40","author":"Pepine","year":"2017","journal-title":"Clin. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00325481.2018.1412799","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited","volume":"130","author":"Walker","year":"2018","journal-title":"Postgrad. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1017\/S0266462309090242","article-title":"Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis","volume":"25","author":"Inotai","year":"2009","journal-title":"Int. J. Technol. Assess Health Care"},{"key":"ref_62","first-page":"762","article-title":"Risk of myocardial infarction associated with selective COX-2 inhibitors: Meta-analysis of randomised controlled trials","volume":"16","author":"Chen","year":"2007","journal-title":"Pharm. Drug Saf."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_65","first-page":"714","article-title":"Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis","volume":"30","author":"Singh","year":"2003","journal-title":"J. Rheumatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Park, M.H., and Hong, J.T. (2016). Roles of NF-\u03baB in cancer and inflammatory diseases and their therapeutic approaches. Cells, 5.","DOI":"10.3390\/cells5020015"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.00-0529fje","article-title":"Aspirin-induced activation of the NF-kappaB signaling pathway: A novel mechanism for aspirin-mediated apoptosis in colon cancer cells","volume":"15","author":"Stark","year":"2001","journal-title":"FASEB J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1016\/j.febslet.2005.06.049","article-title":"Diclofenac attenuates Wnt\/\u03b2-catenin signaling in colon cancer cells by activation of NF-\u03baB","volume":"579","author":"Cho","year":"2005","journal-title":"FEBS Lett."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1566524013363816","article-title":"Role of the NF-kappaB pathway in the pathogenesis of human disease states","volume":"1","author":"Yamamoto","year":"2001","journal-title":"Mol. Med. Curr. Mol. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1074\/jbc.274.38.27307","article-title":"BSulindac inhibits activation of the NF-kappaB pathway","volume":"274","author":"Yamamoto","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"27613","DOI":"10.1074\/jbc.M201119200","article-title":"Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line","volume":"277","author":"Arico","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Benelli, R., Barboro, P., Costa, D., Astigiano, S., Barbieri, O., Capaia, M., Poggi, A., and Ferrari, N. (2019). Multifocal signal modulation therapy by celecoxib: A strategy for managing castration-resistant prostate cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20236091"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/1940-6207.CAPR-13-0288","article-title":"Naproxen Induces Cell-Cycle Arrest and Apoptosis in Human Urinary Bladder Cancer Cell Lines and Chemically Induced Cancers by Targeting PI3K","volume":"7","author":"Kim","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","article-title":"Peroxisome proliferator-activated receptors \u03b1 and \u03b3 are activated by indomethacin and other non-steroidal anti-inflammatory drugs","volume":"272","author":"Lehmann","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0092-8674(00)81664-5","article-title":"PPAR\u03b4 Is an APC-regulated target of nonsteroidal anti-inflammatory drugs","volume":"99","author":"He","year":"1999","journal-title":"Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1073\/pnas.051630998","article-title":"Genetic disruption of Genetic disruption of PPAR\u03b4 decreases the tumorigenicity of human colon cancer cells","volume":"98","author":"Park","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.canlet.2008.10.023","article-title":"Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells","volume":"275","author":"Sun","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_80","first-page":"785","article-title":"A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB and steroid hormone receptors","volume":"26","author":"Narayanan","year":"2005","journal-title":"Int. J. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1016\/S0024-3205(01)01411-4","article-title":"MAPK (ERK2) kinase\u2014A key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth","volume":"69","author":"Husain","year":"2001","journal-title":"Life Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2007.01.071","article-title":"Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT","volume":"563","author":"Ou","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s003840100301","article-title":"Prolonged activation of mitogen-activated protein kinases during NSAID-induced apoptosis in HT-29 colon cancer cells","volume":"16","author":"Kim","year":"2001","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.10330","article-title":"The MEK\/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells","volume":"99","author":"Elder","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1535-7163.51.4.1","article-title":"Selective inhibitors of MEK1\/ERK44\/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells","volume":"4","author":"Sun","year":"2005","journal-title":"Mol. Cancer Therap."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.biopha.2014.09.006","article-title":"Upregulation of MAPK\/Erk and PI3K\/Akt pathways in ulcerative colitis-associated colon cancer","volume":"68","author":"Setia","year":"2014","journal-title":"Biomed. Pharm."},{"key":"ref_87","first-page":"875","article-title":"Celecoxib enhances apoptosis of the liver cancer cells via regulating ERK\/JNK\/P38 pathway","volume":"26","author":"Jia","year":"2021","journal-title":"J. Buon"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/CAD.0b013e32833dada8","article-title":"Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines","volume":"21","author":"Park","year":"2010","journal-title":"Anticancer Drugs"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2012.02.017","article-title":"Genetic and pharmacologic inhibition of \u03b2-catenin targets imatinib-resistant leukemia stem cells in CML","volume":"10","author":"Bullinger","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2007.12.034","article-title":"Sulindac suppresses \u03b2-catenin expression in human cancer cells","volume":"583","author":"Han","year":"2008","journal-title":"Eur. J. Pharm."},{"key":"ref_91","first-page":"885","article-title":"Sulindac metabolites induce caspase- and proteasome-dependent degradation of \u03b2-catenin protein in human colon cancer cells","volume":"2","author":"Rice","year":"2003","journal-title":"Mol. Cancer Therap."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.bjc.6601505","article-title":"Sulindac targets nuclear \u03b2-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines","volume":"90","author":"Boon","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s11064-013-1142-9","article-title":"Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt\/\u03b2-catenin\/Tcf signaling pathway in human glioblastoma cells","volume":"38","author":"Sareddy","year":"2013","journal-title":"Neurochem. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"115254","DOI":"10.18632\/oncotarget.23250","article-title":"Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E and down-regulating the Wnt pathway activity","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1158\/1535-7163.MCT-09-0758","article-title":"Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition elevation of cyclic GMP and activation of protein kinase G","volume":"8","author":"Tinsley","year":"2009","journal-title":"Mol. Cancer Therap."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1940-6207.CAPR-10-0030","article-title":"Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition","volume":"3","author":"Tinsley","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1158\/1940-6207.CAPR-11-0095","article-title":"Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt\/\u03b2-catenin-mediated transcription in human breast tumor cells","volume":"4","author":"Tinsley","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1158\/1535-7163.MCT-13-0048","article-title":"Sulindac selectively inhibits colon tumor cell growth by activating the cGMP\/PKG pathway to suppress Wnt\/\u03b2-catenin signaling","volume":"12","author":"Li","year":"2013","journal-title":"Mol. Cancer Therap."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2012.02.050","article-title":"Aspirin inhibits mTOR signaling activates amp-activated protein kinase and induces autophagy in colorectal cancer cells","volume":"142","author":"Din","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zhang, P., He, D., Song, E., Jiang, M., and Song, Y. (2019). Celecoxib enhances the sensitivity of non-small-cell lung cancer Cells to radiation-induced apoptosis through downregulation of the Akt\/mTOR signaling pathway and COX-2 expression. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223760"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.biopha.2016.11.026","article-title":"Celecoxib exerts antitumor effects in HL-60 acute leukemia cells and inhibits autophagy by affecting lysosome function","volume":"84","author":"Lu","year":"2016","journal-title":"Biomed. Pharm."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/auto.6.2.11124","article-title":"Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells","volume":"6","author":"Huang","year":"2010","journal-title":"Autophagy"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Huang, K.H., Kuo, K.L., Ho, I.L., Chang, H.C., Chuang, Y.T., Lin, W.C., Lee, P.Y., Chang, S.C., Chiang, C.K., and Pu, Y.S. (2013). Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082034"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/cpr.12221","article-title":"Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress","volume":"48","author":"Zhong","year":"2015","journal-title":"Cell Prolif."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Dong, X., Li, R., Xiu, P., Dong, X., Xu, Z., Zhai, B., Liu, F., Jiang, H., Sun, X., and Li, J. (2014). Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2- dependent and -independent pathways. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092864"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/jcmm.12461","article-title":"Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT-737","volume":"19","author":"Zhang","year":"2015","journal-title":"J. Cell Mol. Med."},{"key":"ref_107","first-page":"1","article-title":"COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib","volume":"15","author":"Tegeder","year":"2001","journal-title":"FASEB J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1535-7163.MCT-04-0201","article-title":"The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1\/MIC-1\/GDF-15","volume":"4","author":"Kim","year":"2005","journal-title":"Mol. Cancer Therap."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.bbagen.2012.09.015","article-title":"Stimulation of cytosolic and mitochondrial calcium mobilization by indomethacin in Caco-2 cells: Modulation by the polyphenols quercetin resveratrol and rutin","volume":"1820","author":"Pastene","year":"2012","journal-title":"Biochim. Biophys. Acta (Bba)\u2014Gen. Subj."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.neo.7900097","article-title":"Indomethacin-Induced Apoptosis in Esophageal Adenocarcinoma Cells Involves Upregulation of Bax and Translocation of Mitochondrial Cytochrome C Independent of COX-2 Expression","volume":"2","author":"Aggarwal","year":"2000","journal-title":"Neoplasia"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.bcp.2003.12.014","article-title":"Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells","volume":"67","author":"Maier","year":"2004","journal-title":"Biochem. Pharm."},{"key":"ref_112","first-page":"2343","article-title":"Effects of celecoxib on cycle kinetics of gastric cancer cells and protein expression of cytochrome C and caspase-9. Asian Pac","volume":"14","author":"Wang","year":"2013","journal-title":"J. Cancer Prev."},{"key":"ref_113","first-page":"1010","article-title":"Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway","volume":"7","author":"Li","year":"2001","journal-title":"Clinical Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.neo.7900120","article-title":"Aspirin induces apoptosis through release of cytochrome c from mitochondria","volume":"2","author":"Zimmermann","year":"2000","journal-title":"Neoplasia"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1053\/gast.2002.32972","article-title":"Expression and regulation of nonsteroidal anti-inflammatory drug\u2013activated gene (NAG-1) in human and mouse tissue","volume":"122","author":"Kim","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1124\/mol.59.4.901","article-title":"Cyclooxygenase inhibitors regulate the expression of a TGF-\u03b2 superfamily member that has proapoptotic and antitumorigenic activities","volume":"59","author":"Baek","year":"2001","journal-title":"Mol. Pharm."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ijc.26082","article-title":"DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1\/GDF15) in glioma cell lines","volume":"130","author":"Kadowaki","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/carcin\/bgh199","article-title":"Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction which may explain sulindac sulfide induced gastric Cancer Cell apoptosis","volume":"25","author":"Jang","year":"2004","journal-title":"Carcinogenesis"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1124\/jpet.301.3.1126","article-title":"Dual function of nonsteroidal anti-inflammatory drugs (nsaids): Inhibition of cyclooxygenase and induction of NSAID-activated gene","volume":"301","author":"Baek","year":"2002","journal-title":"J. Pharm. Exp. Therap."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1745-7254.2007.00652.x","article-title":"Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide","volume":"28","author":"Huang","year":"2007","journal-title":"Acta Pharm. Sin."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2009.03.006","article-title":"A reciprocal relationship exists between non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) and cyclooxygenase-2","volume":"282","author":"Iguchi","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejphar.2010.10.026","article-title":"Transcript profiling identifies novel key players mediating the growth inhibitory effect of NS-398 on human pancreatic cancer cells","volume":"650","author":"Youns","year":"2011","journal-title":"Eur. J. Pharm."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/1541-7786.MCR-10-0342","article-title":"NSAID Inhibition of Prostate Cancer Cell Migration Is Mediated by Nag-1 Induction via the p38 MAPK-p75NTR Pathway","volume":"8","author":"Wynne","year":"2010","journal-title":"Molecular Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.3390\/molecules18066584","article-title":"Indomethacin inhibits cancer cell migration via attenuation of cellular calcium mobilization","volume":"18","author":"Guo","year":"2013","journal-title":"Molecules"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1042\/bj20020279","article-title":"The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: A plausible link with its anti-tumour effect and cardiovascular risks","volume":"366","author":"Johnson","year":"2002","journal-title":"Biochem. J."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/1535-7163.MCT-06-0629","article-title":"Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib a non-coxib analogue of celecoxib","volume":"6","author":"Pyrko","year":"2007","journal-title":"Mol. Cancer Therap."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Coca, R., Soler, F., Cortes-Castell, E., Gil-Guillen, V., and Fernandez-Belda, F. (2014). Inhibition mechanism of the intracellular transporter Ca2+-Pump from sarco-endoplasmic reticulum by the antitumor agent dimethyl-celecoxib. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102083"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1158\/1078-0432.CCR-17-0242","article-title":"Aspirin inhibits cancer metastasis and angiogenesis via targeting heparanase","volume":"23","author":"Dai","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12079-018-00499-y","article-title":"Aspirin suppresses tumor cell-induced angiogenesis and their incongruity","volume":"13","author":"Maity","year":"2019","journal-title":"J. Cell Commun. Signal."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1007\/s13277-014-2952-3","article-title":"Inhibitory effect of ibuprofen on tumor survival and angiogenesis in gastric cancer cell","volume":"36","author":"Akrami","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1158\/1078-0432.CCR-04-1696","article-title":"Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth angiogenesis metastasis and survival in a mouse model of colorectal cancer","volume":"11","author":"Yao","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_132","first-page":"73","article-title":"Relationship between NSAIDs gastric antisecretory and carbonic anhydrase isoenzyme","volume":"20","author":"Vlad","year":"2015","journal-title":"Acta Med. Trans."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1021\/jm030912m","article-title":"Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib:\u2009 New pharmacological opportunities due to related binding site recognition","volume":"47","author":"Weber","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10753-004-6052-1","article-title":"the cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II","volume":"28","author":"Knudsen","year":"2004","journal-title":"Inflammation"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF03401642","article-title":"Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation","volume":"2","author":"Lee","year":"1996","journal-title":"Mol. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1804000116","article-title":"Aspirin-triggered proresolving mediators stimulate resolution in cancer","volume":"116","author":"Gilligan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3892\/ijmm.2016.2721","article-title":"Aspirin-triggered resolvin D1 inhibits TGF-\u03b21-induced EMT through the inhibition of the mTOR pathway by reducing the expression of PKM2 and is closely linked to oxidative stress","volume":"38","author":"Liu","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Vannitamby, A., Saad, M.I., Aloe, C., Wang, H., Kumar, B., Vlahos, R., Selemidis, S., Irving, L., Steinfort, D., and Jenkins, B.J. (2021). Aspirin-triggered resolvin D1 reduces proliferation and the neutrophil to lymphocyte ratio in a mutant KRAS-driven lung adenocarcinoma model. Cancers, 13.","DOI":"10.3390\/cancers13133224"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm1201-1291","article-title":"Possible new role for NF-\u03baB in the resolution of inflammation","volume":"7","author":"Lawrence","year":"2001","journal-title":"Nat. Med."},{"key":"ref_140","first-page":"3834","article-title":"The TLR4\/NF-\u03baB signaling pathway mediates the growth of colon cancer","volume":"18","author":"Huang","year":"2014","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/labinvest.2016.109","article-title":"Inhibition of NF-kappa B pathway leads to deregulation of epithelial\u2013mesenchymal transition and neural invasion in pancreatic cancer","volume":"96","author":"Nomura","year":"2016","journal-title":"Lab. Investig."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Pires, B.R.B., Mencalha, A.L., Ferreira, G.M., de Souza, W.F., Morgado-D\u00edaz, J.A., Maia, A.M., Corr\u00eaa, S., and Abdelhay, E.S. (2017). NF-kappaB is involved in the regulation of EMT genes in breast cancer cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169622"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1002\/cncr.25190","article-title":"Nuclear factor \u03baB transcription factors are coexpressed and convey a poor outcome in ovarian cancer","volume":"116","author":"Annunziata","year":"2010","journal-title":"Cancer"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1128\/MCB.22.8.2862-2870.2002","article-title":"Charles NF-\u03baB activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer","volume":"22","author":"Sawyers","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/pros.10335","article-title":"Expression of NF-\u03baB in prostate cancer lymph node metastases","volume":"58","author":"Lessard","year":"2004","journal-title":"Prostate"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1038\/bjc.2014.251","article-title":"Immunosuppression through constitutively activated NF-\u03baB signalling in human ovarian cancer and its reversal by an NF-\u03baB inhibitor","volume":"110","author":"Nishio","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_147","first-page":"177","article-title":"Experimental carcinogenesis in the pancreas","volume":"26","author":"Longnecker","year":"1984","journal-title":"Int. Rev. Exp. Pathol."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Kaltschmidt, B., Greiner, J.F., Kadhim, H.M., and Kaltschmidt, C. (2018). Subunit-Specific Role of NF-\u03baB in Cancer. Biomedicines, 6.","DOI":"10.3390\/biomedicines6020044"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gde.2008.01.020","article-title":"NF-\u03baB and cancer\u2014Identifying targets and mechanisms","volume":"18","author":"Naugler","year":"2008","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.2741\/3066","article-title":"TNF: A master switch for inflammation to cancer","volume":"13","author":"Sethi","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.it.2005.04.003","article-title":"Inflammation-associated cancer: NF-\u03baB is the lynchpin","volume":"26","author":"Li","year":"2005","journal-title":"Trends Immunol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bjc.6605530","article-title":"TNF-\u03b1\/NF-\u03baB\/Snail pathway in cancer cell migration and invasion","volume":"102","author":"Wu","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.bbrc.2017.06.148","article-title":"Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-\u03baB pathway","volume":"490","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"a011189","DOI":"10.1101\/cshperspect.a011189","article-title":"Pi3k-PKB\/AKT pathway","volume":"4","author":"Hemmings","year":"2012","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"ref_157","first-page":"2319","article-title":"The Akt pathway in oncology therapy and beyond","volume":"53","author":"Nitulescu","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bjc.2017.153","article-title":"Akt as a target for cancer therapy: More is not always better (lessons from studies in mice)","volume":"117","author":"Wang","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","article-title":"PTEN and the PI3-kinase pathway in cancer","volume":"4","author":"Chalhoub","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"21528","DOI":"10.1074\/jbc.274.31.21528","article-title":"Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent Prostate cancer lines","volume":"274","author":"Nakatani","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"11718","DOI":"10.1158\/0008-5472.CAN-06-1968","article-title":"A specific role for AKT3 in the genesis of ovarian cancer through modulation of G-M phase transition","volume":"66","author":"Cristiano","year":"2006","journal-title":"Cancer Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/B:APPT.0000045801.15585.dd","article-title":"PI3K-Akt pathway: Its functions and alterations in human cancer","volume":"9","author":"Osaki","year":"2004","journal-title":"Apoptosis"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"Hennessy","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1196\/annals.1338.026","article-title":"Celecoxib induces heme-oxygenase expression in glomerular mesangial cells","volume":"1042","author":"Hou","year":"2005","journal-title":"Ann. New York Acad. Sci."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s10020-020-0139-5","article-title":"Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K\/Akt\/raptor pathway","volume":"26","author":"Chen","year":"2020","journal-title":"Mol. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Ann. Rev. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharm. Rev."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/2030","article-title":"Differentiation and reversal of malignant changes in colon cancer through PPARgamma","volume":"4","author":"Sarraf","year":"1998","journal-title":"Nat. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0090-4295(02)01747-8","article-title":"Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists","volume":"60","author":"Hase","year":"2002","journal-title":"Urology"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1038\/oncsis.2016.41","article-title":"PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions","volume":"5","author":"Wang","year":"2016","journal-title":"Oncogenesis"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0016-5085(98)70072-1","article-title":"Activation of PPAR\u03b3 leads to inhibition of anchorage-independent growth of human colorectal cancer cells","volume":"115","author":"Brockman","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc1254","article-title":"Peroxisome-proliferator-activated receptors and cancers: Complex stories","volume":"4","author":"Michalik","year":"2004","journal-title":"Nat. Nat. Rev. Cancer"},{"key":"ref_173","first-page":"2424","article-title":"Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats","volume":"61","author":"Tanaka","year":"2001","journal-title":"Cancer Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1053\/gast.2003.50067","article-title":"Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice","volume":"124","author":"Osawa","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/2042","article-title":"Activators of the nuclear receptor PPARgamma enhance colon polyp formation","volume":"4","author":"Saez","year":"1998","journal-title":"Nat. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/2036","article-title":"Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL\/6J-APCMin\/+ mice","volume":"4","author":"Lefebvre","year":"1998","journal-title":"Nat. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1073\/pnas.94.7.3308","article-title":"Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice","volume":"94","author":"Wasan","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/CS20080022","article-title":"Role of peroxisome-proliferator-activated receptor beta\/delta (PPARbeta\/delta) in gastrointestinal tract function and disease","volume":"115","author":"Peters","year":"2008","journal-title":"Clin. Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/carcin\/19.11.1989","article-title":"Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver","volume":"19","author":"Peters","year":"1998","journal-title":"Carcinogenesis"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"8992","DOI":"10.1038\/sj.onc.1208143","article-title":"PPAR\u03b4 status and Apc-mediated tumourigenesis in the mouse intestine","volume":"23","author":"Reed","year":"2004","journal-title":"Oncogene"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"9968","DOI":"10.1073\/pnas.1631086100","article-title":"The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-\u03b4 to induce apoptosis in colorectal cancer cells","volume":"100","author":"Shureiqi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1073\/pnas.94.12.6148","article-title":"Discovery of a second 15S-lipoxygenase in humans","volume":"94","author":"Brash","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-291X(05)81260-4","article-title":"In vivo activation of an omega-6 oxygenase in human skin","volume":"180","author":"Baer","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_184","first-page":"360","article-title":"Expression of 15-lipoxygenase-1 in human colorectal cancer","volume":"59","author":"Ikawa","year":"1999","journal-title":"Cancer Res."},{"key":"ref_185","first-page":"6846","article-title":"15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells","volume":"60","author":"Shureiqi","year":"2000","journal-title":"Cancer Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"102737","DOI":"10.1155\/2008\/102737","article-title":"The Role of PPARs in Cancer","volume":"2008","author":"Tachibana","year":"2008","journal-title":"PPAR Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta (Bba)\u2013Mol. Basis Dis."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1038\/sj.onc.1210392","article-title":"Differential regulation and properties of MAPKs","volume":"26","author":"Raman","year":"2007","journal-title":"Oncogene"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/rheumatology\/kem297","article-title":"MAPKs and their relevance to arthritis and inflammation","volume":"47","author":"Thalhamer","year":"2008","journal-title":"Rheumatology"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"352371","DOI":"10.1155\/2014\/352371","article-title":"Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses","volume":"2014","author":"Yang","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s13238-010-0019-9","article-title":"MAPK signaling in inflammation-associated cancer development","volume":"1","author":"Huang","year":"2010","journal-title":"Protein Cell Cell"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Chen, Y., Zhang, Y., Chen, S., Liu, W., Lin, Y., Zhang, H., and Yu, F. (2021). Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL. Pigment Cell Melanoma Res.","DOI":"10.1111\/pcmr.13021"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1349-7006.2006.00244.x","article-title":"ERK MAP kinase in G1 cell cycle progression and cancer","volume":"97","author":"Torii","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S8756-3282(03)00026-7","article-title":"Activation of the JNK\u2013AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas","volume":"32","author":"Papachristou","year":"2003","journal-title":"Bone"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Avisetti, D.R., Babu, K.S., and Kalivendi, S.V. (2014). Activation of p38\/JNK pathway is responsible for embelin induced apoptosis in lung cancer cells: Transitional role of reactive oxygen species. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087050"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.onc.1204162","article-title":"NF-kappaB p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps","volume":"20","author":"Hardwick","year":"2001","journal-title":"Oncogene"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: The first 30 years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat. Nat. Rev. Cancer"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ng.115","article-title":"Differential effects of oncogenic K-Ras and N-Ras on proliferation differentiation and tumor progression in the colon","volume":"40","author":"Haigis","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/327293a0","article-title":"Prevalence of ras gene mutations in human colorectal cancers","volume":"327","author":"Bos","year":"1987","journal-title":"Nature"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/327298a0","article-title":"Detection of high incidence of K-ras oncogenes during human colon tumorigenesis","volume":"327","author":"Forrester","year":"1987","journal-title":"Nature"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM198710083171504","article-title":"Mutational Activation of the K-ras Oncogene","volume":"317","author":"Rodenhuis","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","article-title":"Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes","volume":"53","author":"Almoguera","year":"1988","journal-title":"Cell"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/sj.onc.1202174","article-title":"Increasing complexity of Ras signaling","volume":"17","author":"Campbell","year":"1998","journal-title":"Oncogene"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198809013190901","article-title":"Genetic alterations during colorectal-tumor development","volume":"319","author":"Vogelstein","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/ijc.23383","article-title":"Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon","volume":"122","author":"Calcagno","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1073\/pnas.94.7.2869","article-title":"Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase\/stress-activated protein kinase\u2009activation","volume":"94","author":"Schwenger","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1097-4652(199904)179:1<109::AID-JCP13>3.0.CO;2-W","article-title":"Cell-type-specific activation of c-Jun N-terminal kinase by salicylates","volume":"179","author":"Schwenger","year":"1999","journal-title":"J. Cell. Physiol."},{"key":"ref_210","first-page":"981","article-title":"Effects of aspirin on hepatocellular carcinoma and its potential molecular mechanism","volume":"25","author":"Yuan","year":"2020","journal-title":"J. Buon"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Sun, J., Guo, C., Zheng, W., and Zhang, X. (2019). Aspirin inhibits proliferation and promotes apoptosis of hepatocellular carcinoma Cells via wnt\/\u03b2-catenin signaling pathway. Panminerva Med.","DOI":"10.23736\/S0031-0808.19.03722-4"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3389\/fimmu.2019.02293","article-title":"WNT\/\u03b2-catenin signaling pathway regulating t cell-inflammation in the tumor microenvironment","volume":"10","author":"Li","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_213","first-page":"310183","article-title":"The Wnt\u03b2-Catenin signaling pathway controls the inflammatory response in infections caused by pathogenic bacteria","volume":"2014","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejca.2004.11.005","article-title":"Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance","volume":"41","author":"Doucas","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-017-0471-6","article-title":"Wnt\/beta-catenin pathway: Modulating anticancer immune response","volume":"10","author":"Pai","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fimmu.2016.00460","article-title":"Modulation of inflammatory responses by wnt\/\u03b2-catenin signaling in dendritic cells: A novel immunotherapy target for autoimmunity and cancer","volume":"7","author":"Suryawanshi","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3389\/fimmu.2016.00378","article-title":"Crosstalk between Wnt\/\u03b2-Catenin and NF-\u03baB Signaling Pathway during Inflammation","volume":"7","author":"Ma","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.4049\/jimmunol.1400614","article-title":"TLR2-dependent activation of \u03b2-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammation","volume":"193","author":"Manoharan","year":"2014","journal-title":"J. Immunol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"10747","DOI":"10.1073\/pnas.0604206103","article-title":"Aberrant Wnt\/\u03b2-catenin signaling can induce chromosomal instability in colon cancer","volume":"103","author":"Hadjihannas","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"37257","DOI":"10.18632\/oncotarget.6133","article-title":"Wnt2 complements Wnt\/\u03b2-catenin signaling in colorectal cancer","volume":"6","author":"Jung","year":"2015","journal-title":"Oncotarget"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1078-0432.CCR-07-1644","article-title":"wnt5a exhibits tumor-suppressive activity through antagonizing the Wnt\/\u03b2-catenin signaling and is frequently methylated in colorectal cancer","volume":"14","author":"Ying","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_222","first-page":"566","article-title":"MicroRNA-374a activates Wnt\/\u03b2-catenin signaling to promote breast cancer metastasis","volume":"123","author":"Cai","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcb.23350","article-title":"The wnt\/\u03b2-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer","volume":"113","author":"King","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.1038\/srep12465","article-title":"Blockade of Wnt\/\u03b2-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype","volume":"5","author":"Jang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.clml.2016.06.004","article-title":"Canonical Wnt\/\u03b2-catenin signaling pathway is dysregulated in patients with primary and secondary myelofibrosis","volume":"16","author":"Lucijanic","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13045-015-0161-1","article-title":"Targeting Wnt pathway in mantle cell lymphoma-initiating cells","volume":"8","author":"Mathur","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.clml.2015.08.084","article-title":"The Role of \u03b2-catenin in Bcr\/Abl negative myeloproliferative neoplasms: An immunohistochemical study","volume":"15","author":"Geduk","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1158\/0008-5472.CAN-14-2377","article-title":"\u03b2-catenin promotes regulatory T-cell responses in tumors by inducing vitamin a metabolism in dendritic cells","volume":"75","author":"Hong","year":"2015","journal-title":"Cancer Res."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ccr.2011.10.030","article-title":"\u03b2-Catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas","volume":"20","author":"Damsky","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/onc.2012.229","article-title":"Beta-catenin inhibits melanocyte migration but induces melanoma metastasis","volume":"32","author":"Gallagher","year":"2013","journal-title":"Oncogene"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ng.192","article-title":"Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt\/\u03b2-catenin signaling","volume":"40","author":"Andl","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Vall\u00e9e, A., Lecarpentier, Y., and Vall\u00e9e, J.N. (2019). Targeting the canonical WNT\/\u03b2-catenin pathway in cancer treatment using non-steroidal anti-inflammatory drugs. Cells, 8.","DOI":"10.3390\/cells8070726"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/cbin.10959","article-title":"Ibuprofen reduces Cell Prolif.eration through inhibiting Wnt\/\u03b2 catenin signaling pathway in gastric cancer stem cells","volume":"42","author":"Akrami","year":"2018","journal-title":"Cell Biol. Int."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/er.2013-1053","article-title":"Clinical and molecular genetics of the phosphodiesterases (PDEs)","volume":"35","author":"Azevedo","year":"2014","journal-title":"Endocr. Rev."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3835(01)00764-9","article-title":"Epinephrine inhibits invasion of oral squamous carcinoma cells by modulating intracellular cAMP","volume":"176","author":"Yamanaka","year":"2002","journal-title":"Cancer Lett."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bcp.2004.05.026","article-title":"Phosphodiesterase inhibitors as anti-cancer drugs","volume":"68","author":"Hirsh","year":"2004","journal-title":"Biochem. Pharm."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2002-01-0075","article-title":"Sildenafil and vardenafil types 5 and 6 phosphodiesterase inhibitors induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells","volume":"101","author":"Sarfati","year":"2003","journal-title":"Blood"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/onc.2014.94","article-title":"Phosphodiesterase 10A: A novel target for selective inhibition of colon tumor cell growth and \u03b2-catenin-dependent TCF transcriptional activity","volume":"34","author":"Li","year":"2015","journal-title":"Oncogene"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.drudis.2020.06.008","article-title":"PDE5 and PDE10 inhibition activates cGMP\/PKG signaling to block Wnt\/\u03b2-catenin transcription cancer cell growth and tumor immunity","volume":"25","author":"Piazza","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"69264","DOI":"10.18632\/oncotarget.20566","article-title":"Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking \u03b2-catenin and MAPK signaling","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR Signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: Progress and challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00432-014-1803-3","article-title":"Current clinical regulation of PI3K\/PTEN\/Akt\/mTOR signalling in treatment of human cancer","volume":"141","author":"Lim","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/onc.2015.179","article-title":"Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP","volume":"35","author":"Ricoult","year":"2016","journal-title":"Oncogene"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"25224","DOI":"10.18632\/oncotarget.8279","article-title":"mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2\/PIK3CA-hyperactive breast cancer","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Hsieh","year":"2012","journal-title":"Nature"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","article-title":"mTORC2 Promotes Tumorigenesis via Lipid Synthesis","volume":"32","author":"Guri","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1126\/science.aag2553","article-title":"Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth","volume":"356","author":"Siciliano","year":"2017","journal-title":"Science"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-419X(03)00004-0","article-title":"Autophagy: A barrier or an adaptive response to cancer","volume":"1603","author":"Codogno","year":"2003","journal-title":"Biochim. Biophys. Acta (Bba)\u2014Rev. Cancer"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.biochem.69.1.303","article-title":"Autophagy cytoplasm-to-vacuole targeting pathway and pexophagy in yeast and mammalian cells","volume":"69","author":"Kim","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/sj.cdd.4401359","article-title":"Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells","volume":"11","author":"Kanzawa","year":"2004","journal-title":"Cell Death Differ"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4161\/cbt.21793","article-title":"Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells","volume":"13","author":"Dickstein","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"ref_253","first-page":"439","article-title":"A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles","volume":"61","author":"Paglin","year":"2001","journal-title":"Cancer Res."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/cam4.1287","article-title":"Autophagy: Novel applications of nonsteroidal anti-inflammatory drugs for primary cancer","volume":"7","author":"Yu","year":"2018","journal-title":"Cancer Med."},{"key":"ref_255","first-page":"3917","article-title":"The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells","volume":"118","author":"Lu","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"56698","DOI":"10.18632\/oncotarget.18082","article-title":"Inhibition of the PI3K\/AKT\/mTOR pathway activates autophagy and compensatory Ras\/Raf\/MEK\/ERK signalling in prostate cancer","volume":"8","author":"Butler","year":"2017","journal-title":"Oncotarget"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"36883","DOI":"10.1074\/jbc.M607094200","article-title":"Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling","volume":"281","author":"Kim","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl2 family: Regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1073\/pnas.95.9.4997","article-title":"Bax directly induces release of cytochrome c from isolated mitochondria","volume":"95","author":"Xie","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0005-2728(98)00109-1","article-title":"Mitochondrial control of apoptosis: The role of cytochrome c","volume":"1366","author":"Cai","year":"1998","journal-title":"Biochim. Biophys. Acta (Bba)\u2014Bioenerg."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/35060","article-title":"Injected cytochrome c induces apoptosis","volume":"391","author":"Zhivotovsky","year":"1998","journal-title":"Nature"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bcp.2012.11.025","article-title":"The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1\/GDF15) in cancer","volume":"85","author":"Wang","year":"2013","journal-title":"Biochem. Pharm."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1124\/jpet.105.100081","article-title":"Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene\/macrophage inhibitory cytokine-1\/prostate-derived factor a putative tumor suppressor inhibits tumor growth","volume":"318","author":"Martinez","year":"2006","journal-title":"J. Pharm. Exp. Therap."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000277599","article-title":"Analysis of NSAID-activated gene 1 expression in prostate cancer","volume":"84","author":"Kawahara","year":"2010","journal-title":"Urol. Int."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrc2171","article-title":"Calcium and cancer: Targeting Ca2+ transport","volume":"7","author":"Monteith","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Panda, S., Chatterjee, O., Roy, L., and Chatterjee, S. (2021). Targeting Ca2+ signaling: A new arsenal against cancer. Drug Discov. Today.","DOI":"10.1016\/j.drudis.2021.11.012"},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Ibrahim, S., Dakik, H., Vandier, C., Chautard, R., Paintaud, G., Mazurier, F., Lecomte, T., Gu\u00e9guinou, M., and Raoul, W. (2019). Expression profiling of calcium channels and calcium-activated potassium channels in colorectal cancer. Cancers, 11.","DOI":"10.3390\/cancers11040561"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.3892\/ol.2017.6457","article-title":"Voltage-gated calcium channels: Novel targets for cancer therapy","volume":"14","author":"Phan","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Sritangos, P., Pena Alarcon, E., James, A.D., Sultan, A., Richardson, D.A., and Bruce, J.I. (2020). Plasma Membrane Ca(2+) ATPase isoform 4 (PMCA4) has an important role in numerous hallmarks of pancreatic cancer. Cancers, 12.","DOI":"10.3390\/cancers12010218"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/pros.23879","article-title":"T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cells","volume":"79","author":"Silvestri","year":"2019","journal-title":"Prostate"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1755-148X.2012.00978.x","article-title":"Functional expression of voltage-gated calcium channels in human melanoma","volume":"25","author":"Das","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"26309","DOI":"10.18632\/oncotarget.25241","article-title":"Deregulation of calcium homeostasis in Bcr-Abl-dependent chronic myeloid leukemia","volume":"9","author":"Cabanas","year":"2018","journal-title":"Oncotarget"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","article-title":"Angiogenesis in cancer","volume":"2","author":"Nishida","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor Angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nm0295-149","article-title":"Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression","volume":"1","author":"Holmgren","year":"1995","journal-title":"Nat. Med."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"14888","DOI":"10.1073\/pnas.96.26.14888","article-title":"Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis","volume":"96","author":"Streit","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng1855","article-title":"Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster","volume":"38","author":"Dews","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7243\/2049-7962-1-3","article-title":"Apoptosis angiogenesis and cancer therapies","volume":"1","author":"Tiwari","year":"2012","journal-title":"J. Cancer Ther. Res."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00109-003-0479-y","article-title":"Inhibition of angiogenesis by NSAIDs: Molecular mechanisms and clinical implications","volume":"81","author":"Tarnawski","year":"2003","journal-title":"J. Mol. Med."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2004","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Singh, S., Lomelino, C.L., Mboge, M.Y., Frost, S.C., and McKenna, R. (2018). Cancer drug development of carbonic anhydrase inhibitors beyond the active site. Molecules, 23.","DOI":"10.3390\/molecules23051045"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2559.2006.02523.x","article-title":"Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours","volume":"49","author":"Hynninen","year":"2006","journal-title":"Histopathology"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00432-005-0068-2","article-title":"Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer","volume":"132","author":"Kim","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1158\/1078-0432.CCR-11-0238","article-title":"Noninvasive Detection of Breast Cancer Lymph Node Metastasis Using Carbonic Anhydrases IX and XII Targeted Imaging Probes","volume":"18","author":"Tafreshi","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.bjc.6603530","article-title":"Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer","volume":"96","author":"Hussain","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004180000181","article-title":"Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours","volume":"114","author":"Parkkila","year":"2000","journal-title":"Histochem. Cell Biol."},{"key":"ref_290","doi-asserted-by":"crossref","unstructured":"J\u00e4rvel\u00e4, S., Parkkila, S., Bragge, H., K\u00e4hk\u00f6nen, M., Parkkila, A.K., Soini, Y., Pastorekova, S., Pastorek, J., and Haapasalo, H. (2008). Carbonic anhydrase IX in oligodendroglial brain tumors. BMC Cancer, 8.","DOI":"10.1186\/1471-2407-8-1"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Serhan Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10555-011-9311-2","article-title":"Role of lipoxins resolvins and other bioactive lipids in colon and pancreatic cancer","volume":"30","author":"Janakiram","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prostaglandins.2012.01.005","article-title":"Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation","volume":"97","author":"Weylandt","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"107879","DOI":"10.1016\/j.pharmthera.2021.107879","article-title":"Resolution of inflammation: An organizing principle in biology and medicine","volume":"227","author":"Panigrahy","year":"2021","journal-title":"Pharm. Ther."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and protectins in inflammation resolution","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem. Rev."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1073\/pnas.81.17.5335","article-title":"Lipoxins: Novel series of biologically active compounds formed from arachidonic acid in human leukocytes","volume":"81","author":"Serhan","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_297","first-page":"397","article-title":"Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome","volume":"1851","author":"Serhan","year":"2015","journal-title":"Biochim. Biophys. Acta (Bba)\u2014Mol. Cell Biol. Lipids"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.canlet.2008.03.044","article-title":"Multi-targeted therapy of cancer by omega-3 fatty acids","volume":"269","author":"Berquin","year":"2008","journal-title":"Cancer Lett."},{"key":"ref_300","doi-asserted-by":"crossref","unstructured":"Ding, Y., Mullapudi, B., Torres, C., Mascari\u00f1as, E., Mancinelli, G., Diaz, A.M., McKinney, R., Barron, M., Schultz, M., and Heiferman, M. (2018). Omega-3 fatty acids prevent early pancreatic carcinogenesis via repression of the AKT pathway. Nutrients, 10.","DOI":"10.3390\/nu10091289"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1093\/carcin\/bgm166","article-title":"Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids","volume":"28","author":"Nowak","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/carcin\/bgr049","article-title":"Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-\u03b1","volume":"32","author":"Weylandt","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"107670","DOI":"10.1016\/j.pharmthera.2020.107670","article-title":"Carcinogenesis: Failure of resolution of inflammation?","volume":"218","author":"Fishbein","year":"2021","journal-title":"Pharm. Ther."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"213","DOI":"10.18632\/oncotarget.27442","article-title":"Cytokine storm during chemotherapy: A new companion diagnostic emerges?","volume":"11","author":"Filippou","year":"2020","journal-title":"Oncotarget"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ajpath.2020.06.010","article-title":"Eicosanoids: The overlooked storm in coronavirus disease 2019 (COVID-19)?","volume":"190","author":"Hammock","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10555-020-09889-4","article-title":"Inflammation resolution: A dual-pronged approach to averting cytokine storms in COVID-19?","volume":"39","author":"Panigrahy","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fimmu.2012.00298","article-title":"Pro-resolving lipid mediators (SPMs) and their actions in regulating mirna in novel resolution circuits in inflammation","volume":"3","author":"Recchiuti","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: Signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.plefa.2005.05.020","article-title":"Design synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins","volume":"73","author":"Petasis","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1100\/tsw.2010.113","article-title":"Lipoxin and aspirin-triggered lipoxins","volume":"10","author":"Romano","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Serhan","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1172\/JCI116601","article-title":"Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers","volume":"92","author":"Colgan","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI42545","article-title":"Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation","volume":"121","author":"Oh","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"22663","DOI":"10.1074\/jbc.271.37.22663","article-title":"The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3","volume":"271","author":"Capdevila","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.chembiol.2006.09.011","article-title":"Resolvin E2: Identification and anti-inflammatory actions: Pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis","volume":"13","author":"Tjonahen","year":"2006","journal-title":"Chem. Biol."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: A Family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments anti-inflammatory properties and enzymatic inactivation","volume":"282","author":"Sun","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nm.3911","article-title":"Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections","volume":"21","author":"Dalli","year":"2015","journal-title":"Nat. Med."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2013.10.008","article-title":"Lipid mediators in immune dysfunction after severe inflammation","volume":"35","author":"Fullerton","year":"2014","journal-title":"Trends Immunol."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","article-title":"Anti-inflammatory actions of neuroprotectin D1\/Protectin D1 and its natural stereoisomers: Assignments of dihydroxy-containing docosatrienes","volume":"176","author":"Serhan","year":"2006","journal-title":"J. Immunol."},{"key":"ref_322","doi-asserted-by":"crossref","unstructured":"Deng, B., Wang, C.W., Arnardottir, H.H., Li, Y., Cheng, C.Y.C., Dalli, J., and Serhan, C.N. (2014). Maresin Biosynthesis and identification of Maresin 2 a new anti-inflammatory and pro-resolving mediator from human macrophages. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102362"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.chembiol.2011.06.008","article-title":"Novel proresolving aspirin-triggered DHA pathway","volume":"18","author":"Fredman","year":"2011","journal-title":"Chem. Biol."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1096\/fj.13-227728","article-title":"The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1) inhibits leukotriene A4 hydrolase (LTA4H) and shifts macrophage phenotype","volume":"27","author":"Dalli","year":"2013","journal-title":"FASEB J."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1096\/fj.11-201442","article-title":"Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain","volume":"26","author":"Serhan","year":"2012","journal-title":"FASEB J."},{"key":"ref_327","doi-asserted-by":"crossref","unstructured":"Mudge, D., Kieran, M.W., Bielenberg, D., Benny, O., Dalli, J., Huang, S., Serhan, C.N., and Panigrahy, D. (2014, January 5\u20139). Maresin 1: A potent endogenous anti-inflammatory and pro-resolving inhibitor of primary tumor growth and metastasis. Proceedings of the AACR Annual Meeting, San Diego, CA, USA.","DOI":"10.1158\/1538-7445.AM2014-1170"},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"698.3","DOI":"10.1096\/fasebj.30.1_supplement.698.3","article-title":"Control of breast cancer through the resolution of inflammation","volume":"30","author":"Vatnick","year":"2016","journal-title":"FASEB J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1432\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:08:41Z","timestamp":1760134121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":328,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijms23031432"],"URL":"https:\/\/doi.org\/10.3390\/ijms23031432","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}